|
Volumn 15, Issue 6, 1998, Pages 331-333
|
Indications and limitations of intravenous and subcutaneous midazolam in a palliative care center [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZODIAZEPINE;
DEXAMETHASONE;
FLUMAZENIL;
HALOPERIDOL;
LEVOMEPROMAZINE;
MIDAZOLAM;
MIDAZOLAM MALEATE;
MORPHINE;
ANALGESIA;
CANCER PAIN;
CANCER PALLIATIVE THERAPY;
DRUG EFFICACY;
DRUG INDICATION;
DRUG TOLERABILITY;
HUMAN;
HYPOTENSION;
INTRAVENOUS DRUG ADMINISTRATION;
LETTER;
PRACTICE GUIDELINE;
RESPIRATION DEPRESSION;
SLEEP INDUCTION;
SUBCUTANEOUS DRUG ADMINISTRATION;
AGED;
AGED, 80 AND OVER;
FEMALE;
HUMANS;
HYPNOTICS AND SEDATIVES;
INJECTIONS, INTRAVENOUS;
INJECTIONS, SUBCUTANEOUS;
MALE;
MIDAZOLAM;
MIDDLE AGED;
PALLIATIVE CARE;
|
EID: 0031846471
PISSN: 08853924
EISSN: None
Source Type: Journal
DOI: 10.1016/S0885-3924(98)00020-7 Document Type: Letter |
Times cited : (21)
|
References (12)
|